Publications by authors named "Judy P Sy"

Claim this Profile
R
Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.
David M Brown, Mark Michels, Peter K Kaiser, Jeffrey S Heier, Judy P Sy

Ophthalmology· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ranibizumab versus verteporfin for neovascular age-related macular degeneration.
David M Brown, Peter K Kaiser, Mark Michels, Gisele Soubrane, Jeffrey S Heier, Judy P Sy

N Engl J Med· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study.
Jeffrey S Heier, Andrew N Antoszyk, Peter Reed Pavan, Steven R Leff, Philip J Rosenfeld, Judy P Sy

Ophthalmology· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do growth hormone (GH) serial sampling, insulin-like growth factor-I (IGF-I) or auxological measurements have an advantage over GH stimulation testing in predicting the linear growth response to GH therapy?
Alan D Rogol, Sandra L Blethen, Judy P Sy, Johannes D Veldhuis

Clin Endocrinol (Oxf)· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis